Adaptive clinical trials and master protocols

Andrew McGarry1, Karl Kieburtz2

  • 1Department of Neurology, Cooper University Healthcare at Rowan University, Camden, NJ, United States.

Insights

Adaptive clinical trial designs offer greater flexibility and faster safety and efficacy assessments compared to conventional methods. These innovative approaches optimize trial efficiency and data interpretability for medical interventions.

Area of Science:

  • Clinical Trials Methodology
  • Translational Science
  • Drug Development

Background:

  • Randomized, double-blind, placebo-controlled clinical trials are fundamental in medical research.
  • Evolving scientific knowledge necessitates advancements in clinical trial methodologies.
  • Adaptive trial designs represent a significant evolution in clinical trial methodology.

Purpose of the Study:

  • To summarize general designs, advantages, and pitfalls of adaptive clinical trials.
  • To compare adaptive trial designs with conventional clinical trial designs.
  • To review novel seamless designs and master protocols for improving trial efficiency.

Main Methods:

  • Review of adaptive clinical trial designs.
  • Comparison of adaptive and conventional trial designs.
  • Exploration of seamless designs and master protocols.

Main Results:

  • Adaptive designs allow for modifications (e.g., sample size, criteria) based on interim data.
  • These designs can optimize flexibility and expedite safety and efficacy assessments.
  • Seamless designs and master protocols offer potential improvements in trial efficiency and data interpretability.

Conclusions:

  • Adaptive clinical trials enhance the efficiency and flexibility of evaluating medical interventions.
  • Novel approaches like seamless designs and master protocols further optimize clinical trial processes.
  • These advanced methodologies are crucial for accelerating the assessment of new treatments.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.1K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
6.9K
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
155
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
608
Crossover Experiments01:16

Crossover Experiments

Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K